Convergence Investment Partners’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,792
Closed -$1.29M 268
2026
Q1
$1.29M Buy
+2,792
New +$1.41M 0.21% 167
2025
Q1
Sell
-428
Closed -$223K 279
2024
Q4
$223K Sell
428
-6
-1% -$3.13K 0.05% 233
2024
Q3
$213K Sell
434
-16
-4% -$7.45K 0.06% 227
2024
Q2
$200K Buy
+450
New +$179K 0.06% 238
2023
Q3
Sell
-1,252
Closed -$428K 179
2023
Q2
$428K Buy
+1,252
New +$379K 0.25% 98
2021
Q4
Sell
-1,179
Closed -$391K 245
2021
Q3
$391K Buy
+1,179
New +$396K 0.21% 113
2018
Q3
Sell
-18,666
Closed -$2.98M 334
2018
Q2
$2.98M Buy
18,666
+18,186
+3,789% +$2.77M 0.42% 96
2018
Q1
$66K Buy
+480
New +$67K 0.01% 401
2016
Q4
Sell
-3,447
Closed -$278K 350
2016
Q3
$278K Buy
+3,447
New +$264K 0.04% 307

Other funds holding ISRG

Convergence Investment Partners's ISRG Position: Q2 2026 in Review

Convergence Investment Partners sold out of Intuitive Surgical (ISRG) in Q2 2026, closing a stake of 2,792 shares — an estimated $1.29M sold.

Convergence Investment Partners first reported a position in ISRG in Q3 2016 and held it in 9 quarters. The position peaked at $2.98M in Q2 2018. 2,244 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Convergence Investment Partners reported no remaining Intuitive Surgical position as of Q2 2026 after selling out during the quarter.
  • Convergence Investment Partners sold 2,792 Intuitive Surgical shares in Q2 2026, an estimated $1.29M.
  • Convergence Investment Partners first reported a position in Intuitive Surgical in Q3 2016 and held it in 9 quarters.
  • Convergence Investment Partners's Intuitive Surgical position peaked at $2.98M in Q2 2018.
  • 2,244 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Convergence Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.